From the Guidelines
Hepatobiliary contrast agents, such as mangafodipir trisodium or other hepatocyte-selective contrast agents with biliary excretion, are given during Magnetic Resonance Cholangiopancreatography (MRCP) to assess the biliary tree anatomy and detect bile leaks 1.
Key Characteristics of Hepatobiliary Contrast Agents
- Excreted via bile
- Allow for functional assessment of the biliary tree
- Enable detection and localization of bile leaks with high accuracy
Advantages of MRCP with Hepatobiliary Contrast Agents
- Non-invasive
- No ionizing radiation
- Excellent anatomical information regarding the biliary tree anatomy
- High sensitivity and specificity for detecting bile leaks
Optimal Timing for Hepatobiliary Phase Acquisitions
- Between 60 and 90 min after contrast agent injection 1
Clinical Applications
- Diagnosis of bile duct injuries and bile leaks
- Evaluation of the biliary tree anatomy
- Detection of choledocholithiasis 1
From the Research
Type of Contrast Used in MRCP
- MRCP does not require the use of contrast material or ionizing radiation 2
- However, negative oral contrast media can be used to improve the visualization of the bile and pancreatic ducts 3
- Examples of negative oral contrast agents used in MRCP include:
- The use of negative oral contrast agents can help suppress the signal from the gastrointestinal tract and improve the diagnostic quality of MRCP images 3, 4, 5
- Hepato-biliary contrast agents can also be used in MRCP to provide a higher definition of the biliary tree, both in pathologic and normal conditions 2